The search for a possible optimum adapting dose under the optimum irradiation time scheme in cultured human lymphocytes
by S. Mohammad Javad Mortazavi, Hossein Mozdarani
International Journal of Low Radiation (IJLR), Vol. 3, No. 1, 2006

Abstract: One of the most important questions in adaptive response studies is still the possible existence of an optimum adapting dose. In this study, using the optimum irradiation time scheme (24–48) that was reported by other investigators, we monitored the cytogenetic endpoint of chromosome aberrations to assess the magnitude of adaptation to ionising radiation in the cultured human lymphocytes. Lymphocytes were pre-exposed to an adapting dose of 1–20 cGy at 24 hours, before exposure to an acute challenge dose of 1 or 2 Gy at 48 hours. Cells were fixed at 54 hours. Lymphocytes, which were pretreated with 5 or 10 cGy adapting doses, had significantly fewer chromosome aberrations. In spite of the fact that lymphocytes of some of our blood donors which were pre-treated with 1 or 20 cGy adapting doses, showed an adaptive response, the pooled data (all donors) indicated these two adapting doses cannot induce a significant adaptive response.

Online publication date: Thu, 08-Jun-2006

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Low Radiation (IJLR):
Login with your Inderscience username and password:

    Username:        Password:         

Forgotten your password?


Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com